It has limited value in the early diagnosis of HCC; the sensitivity of AFP is low (54%) with diagnostic levels in only 18% of patients, but it can be useful as a prognostic indicator in some subgroups of patients. This evidence concerns the gene AFP and hepatocellular carcinoma.